Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - - infiltration anathesia - conduction anaesthesia -sympathetic block - therapeutic a diagnostic blocks - neural therapy

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

dentsply limited, united kingdom - prilocaine,felypressin - solution for injection - 30,0.54 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pierrel pharma s.p.a, italy - prilocaine,felypressin - solution for injection - 30,0.54 µ/ml, mg/m

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of inflitration and nerve block techniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 17 july 2003 : lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - prilocaine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000 equivalent to 0.00091% w/v adrenaline acid tartrate; prilocaine hydrochloride 1%{relative} - solution for injection - 1 % - active: adrenaline acid tartrate 1:200000 equivalent to 0.00091% w/v adrenaline acid tartrate prilocaine hydrochloride 1%{relative} excipient: methyl hydroxybenzoate sodium chloride sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000 equivalent to 0.00091% w/v adrenaline acid tartrate; prilocaine hydrochloride 2%{relative} - solution for injection - 2 % - active: adrenaline acid tartrate 1:200000 equivalent to 0.00091% w/v adrenaline acid tartrate prilocaine hydrochloride 2%{relative} excipient: methyl hydroxybenzoate sodium chloride sodium hydroxide sodium metabisulfite water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 5 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - - infiltration anaesthesia - sympathetic block - therapeutic and diagnostic blocks - neural therapy

Canada - English - Health Canada

dentsply canada limited - prilocaine hydrochloride - solution - 40mg - prilocaine hydrochloride 40mg - local anesthetics